Osaka, Japan

Hidekado Tokumoto


Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 89(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations of Hidekado Tokumoto

Introduction

Hidekado Tokumoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the body. With a total of 12 patents to his name, Tokumoto's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, Tokumoto has developed fused benzeneoxyacetic acid derivatives. These compounds possess an agonistic effect on the PGI2 receptor, making them useful for preventing and treating thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcers, and hypertension. Additionally, he has proposed a novel phenoxyacetic acid derivative that also acts as a PGI2 receptor agonist, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Tokumoto's career is marked by his dedication to research and development in the pharmaceutical industry. He works at Ono Pharmaceutical Co., Ltd., a company known for its commitment to advancing healthcare through innovative solutions. His contributions have been instrumental in the creation of new therapeutic options for patients.

Collaborations

Throughout his career, Tokumoto has collaborated with notable colleagues, including Nobuyuki Hamanaka and Kanji Takahashi. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Hidekado Tokumoto's work exemplifies the spirit of innovation in the pharmaceutical field. His patents and collaborations reflect a commitment to improving health outcomes through scientific advancements. His contributions are paving the way for future developments in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…